HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 210 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $40,000 | +14.3% | 2,000 | 0.0% | 0.02% | +6.2% |
| Q3 2017 | $35,000 | +34.6% | 2,000 | 0.0% | 0.02% | +14.3% |
| Q2 2017 | $26,000 | 0.0% | 2,000 | 0.0% | 0.01% | +7.7% |
| Q1 2017 | $26,000 | +30.0% | 2,000 | 0.0% | 0.01% | +44.4% |
| Q4 2016 | $20,000 | -16.7% | 2,000 | 0.0% | 0.01% | -47.1% |
| Q3 2016 | $24,000 | +26.3% | 2,000 | 0.0% | 0.02% | +21.4% |
| Q2 2016 | $19,000 | -5.0% | 2,000 | 0.0% | 0.01% | -6.7% |
| Q1 2016 | $20,000 | -42.9% | 2,000 | 0.0% | 0.02% | -40.0% |
| Q4 2015 | $35,000 | +25.0% | 2,000 | 0.0% | 0.02% | +13.6% |
| Q3 2015 | $28,000 | -37.8% | 2,000 | 0.0% | 0.02% | -35.3% |
| Q2 2015 | $45,000 | +55.2% | 2,000 | 0.0% | 0.03% | +54.5% |
| Q1 2015 | $29,000 | +52.6% | 2,000 | 0.0% | 0.02% | +15.8% |
| Q4 2014 | $19,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |